Full-Time

Director – Data & AI Strategy

Posted on 9/16/2025

Cerebral

Cerebral

501-1,000 employees

Online mental health services with subscriptions

Compensation Overview

$175k - $225k/yr

+ Bonus + Equity

Remote in USA

Remote

Category
Data & Analytics (2)
,
Requirements
  • 7+ years of progressive experience in data leadership roles, ideally within healthcare or health tech
  • Deep expertise in Snowflake, dbt, Looker, and data integrations
  • Strong track record of reporting business and clinical metrics to executives and boards
  • Familiarity with AI/ML concepts (LLMs, predictive models, personalization, automation) and experience driving AI initiatives
  • Excellent stakeholder management, communication, and leadership skills
  • Strategic thinker with the ability to balance long-term vision and immediate execution
  • Prior experience working with healthcare data (EHRs, claims, PHI) in compliance with HIPAA
  • Hands-on skills in SQL and Python
  • Familiarity with regulatory environments and payor/provider systems in mental health
Responsibilities
  • Data Infrastructure & Management: Own and scale our data stack (Snowflake, dbt, Looker) to ensure high-quality, reliable data pipelines; Integrate third-party systems (EHRs, payors, marketing, operations, and product tools) into a unified data ecosystem; Implement best practices for governance, compliance, and security, especially within healthcare/PHI environments (HIPAA)
  • Business Intelligence & Reporting: Define and maintain a source of truth for key business and clinical metrics (patient outcomes, engagement, provider productivity, financial KPIs); Deliver executive-level dashboards and insights to guide decision-making across the leadership team and board; Partner with Product, Engineering, Operations, and Clinical teams to enable data-driven experimentation, forecasting, and continuous improvement
  • AI & Advanced Analytics: Develop and own Cerebral’s AI/ML strategy, identifying opportunities to enhance care delivery, clinical quality, patient experience, and operational efficiency; Partner with product and engineering leaders to shape the roadmap for AI-enabled products (e.g., clinical decision support, patient engagement, automation); Stay ahead of advancements in generative AI and predictive analytics and translate them into safe, ethical, and compliant applications in mental health care
  • Leadership & Strategy: Build and scale a high-performing team of data engineers, analysts, and scientists; Serve as the executive thought partner for data and AI strategy, guiding leadership on opportunities and risks; Foster a culture of data literacy and evidence-based decision-making across the organization

Cerebral provides online mental health services through a subscription-based platform that connects users with licensed therapists and prescribers. Users manage their care via a mobile app to book sessions and receive prescribed medications delivered directly to their door or a local pharmacy. Unlike traditional in-person clinics, this model combines therapy and medication management into a single monthly fee to increase affordability and convenience. The company's goal is to provide a flexible and accessible way for individuals to receive comprehensive, long-term mental health support.

Company Size

501-1,000

Company Stage

Late Stage VC

Total Funding

$487M

Headquarters

San Francisco, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Inflow acquisition taps 6.0% ADHD prevalence where 36.5% adults untreated.
  • $25M funding post-Resilience Labs boosts clinical quality and runway to $487M total.
  • Resilience Labs platform cuts clinician burnout, improving retention and outcomes.

What critics are saying

  • DOJ $3.6M penalty triggers DEA audits halting ADHD stimulant prescriptions.
  • Headspace's 65M users and $335M funding dominate subscription therapy market.
  • Talkspace $30 co-pays undercut Cerebral's $325/month pricing, spurring cancellations.

What makes Cerebral unique

  • Cerebral integrates therapy, medication, and Inflow's ADHD app for continuous care.
  • Subscription model ships medications directly, combining clinical and self-help tools.
  • AI pairs patients with clinicians and tailors messages to boost engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote-first

Medical, dental, vision, & life insurance

401k

Unlimited PTO

Wellness stipend

Bi-quarterly mental health days

No-Meeting-Wednesdays

Social events

Optional company retreats

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-3%
Business Wire
Mar 24th, 2026
Cerebral acquires ADHD app Inflow to expand continuous care beyond clinical appointments

Cerebral, a mental health care provider, has acquired Inflow, a personalised ADHD digital therapeutic app, to expand continuous care options for ADHD patients. The acquisition allows Cerebral to combine clinical care with engagement tools that help patients build skills between appointments. Adult ADHD prevalence in the US has risen from 4.4% historically to 6.0% in 2023, according to the CDC. Approximately 36.5% of adults diagnosed with ADHD receive no formal treatment. Inflow uses cognitive behavioural therapy principles to deliver science-based lessons and daily modules. The app demonstrated significant improvements in ADHD symptoms in an eight-week randomised controlled trial. Both platforms will continue operating separately, though Cerebral clinicians will become more accessible to Inflow members seeking therapy.

Healthcare IT Today
Oct 21st, 2025
Cerebral Raises $25M After Acquisition

Cerebral, a digital mental health company, has raised $25 million in funding following its acquisition of Resilience Labs, a virtual behavioral health care company. The acquisition, announced in August, aims to enhance Cerebral's clinical quality by integrating Resilience Labs' therapy, medication management, and clinician development platform. This move comes as Cerebral seeks to address past criticisms of its prescribing and business practices.

Securities and Exchange Commission
Sep 15th, 2025
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Behavioral Health Business
Sep 12th, 2025
Cerebral Raises $25M Amidst Changes

Cerebral, a digital mental health company, has raised $25 million, following its acquisition of Resilience Labs in August. The acquisition aims to enhance clinical quality by integrating therapy and medication management services. The company has also seen a leadership change, with Brian Reinken as interim CEO. This funding brings Cerebral's total raise to approximately $487 million. Previously, Cerebral faced scrutiny over its ADHD stimulant prescribing practices, resulting in a potential $6.6 million penalty.

CityBiz
Aug 5th, 2025
Cerebral Acquires Resilience Lab for Integration

Cerebral, a virtual mental health provider, has acquired Resilience Lab, a behavioral health organization. This acquisition aims to create a comprehensive mental health delivery system addressing clinical outcome reporting and workforce shortages. The combined entity will integrate psychiatry and therapy, allowing collaborative care decisions. Resilience Lab's clinician development platform will help tackle clinician burnout and turnover, enhancing Cerebral's clinical care standards.

INACTIVE